EN
中文 EN
Company News
Home >Newsroom >Company News
ALL
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2015.10.31
Manufacturing Facility Ground Breaking and Contract-signing Ceremony for Third Round of Financing
2015.03.27
CanSino Biotechnology Successfully Passed EU GMP Audit
2014.12.19
China’s First Ebola Vaccine Approved For Clinical Trials
2014.11.25
CanSinotech submitted CTA of “Diphtheria and Tetanus Toxoids and Component Pertussis Vaccine Adsorbed” to CFDA
2014.09.16
CanSino awarded “Key Overseas Chinese Entrepreneurial Team
2013.05.03
CanSinotech submitted CTA of “AC Meningococcal Conjugate Vaccine” to CFDA
2013.02.26
CanSinotech submitted CTA of “ACW135Y Meningococcal Conjugate Vaccine” to CFDA
2012.05.18
CanSino Vaccine GMP Pilot Production Base Inaugurated
2012.04.11
CanSino and Aeras Partner on Pre-clinical Studies of TB Vaccine Candidates
2007.01.17
CanSino Announces Collaboration with NRC on TB Vaccine Development
1234567